Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

RAC owners planning sale or stock market listing - report

(Sharecast News) - The owners of the RAC roadside recovery service are reportedly preparing to offload the company in a deal which could value it at up to £5bn. According to Sky News, CVC Capital Partners, the Singaporean sovereign investment fund GIC and Silver Lake Partners have been in discussions about plans to launch an auction or a stock market listing of the company.

The RAC, which was founded in 1897, is one of the world's oldest roadside assistance companies. It has about 14 million members, making it nearly as large in customer terms as the AA, its biggest rival.

Sky said a precise valuation of the business was unclear on Thursday, although insiders said a range of between £4bn and £5bn was reasonable.

The AA is also backed by private equity investors who have begun exploring an exit. Sky News revealed earlier this year that Towerbrook Capital Partners, Warburg Pincus and Stonepeak have appointed JP Morgan and Rothschild to conduct a review of the AA's strategic options.

The RAC's shareholders are at an earlier stage of deliberations, with investment banks yet to be appointed, Sky said.

People close to the situation told Sky that any decision about a transaction would not be made until next year, although it is possible that advisers will be hired in the next few months.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.